A Review for the Clinician: Classifications, Genetics, and Treatment for Neuroendocrine Neoplasms of the Thymus (Thymic Carcinoids)

2.

Moran

CA

,

Suster

S

.

Neuroendocrine carcinomas (carcinoid tumor) of the thymus. A clinicopathologic analysis of 80 cases

.

Am J Clin Pathol

.

2000

;

114

(

1

):

100

–

10

.

3.

Soga

J

,

Yakuwa

Y

,

Osaka

M

.

Evaluation of 342 cases of mediastinal/thymic carcinoids collected from literature: a comparative study between typical carcinoids and atypical varieties

.

Ann Thorac Cardiovasc Surg

.

1999

;

5

(

5

):

285

–

92

.

4.

Ströbel

P

,

Zettl

A

,

Shilo

K

,

Chuang

WY

,

Nicholson

AG

,

Matsuno

Y

, et al.

Tumor genetics and survival of thymic neuroendocrine neoplasms: a multi-institutional clinicopathologic study

.

Genes Chromosomes Cancer

.

2014

;

53

(

9

):

738

–

49

.

5.

Goto

K

,

Kodama

T

,

Matsuno

Y

,

Yokose

T

,

Asamura

H

,

Kamiya

N

, et al.

Clinicopathologic and DNA cytometric analysis of carcinoid tumors of the thymus

.

Mod Pathol

.

2001

;

14

(

10

):

985

–

94

.

6.

Dinter

H

,

Bohnenberger

H

,

Beck

J

,

Bornemann-Kolatzki

K

,

Schütz

E

,

Küffer

S

, et al.

Molecular classification of neuroendocrine tumors of the thymus

.

J Thorac Oncol

.

2019

;

14

(

8

):

1472

–

83

.

7.

Filosso

PL

,

Yao

X

,

Ahmad

U

,

Zhan

Y

,

Huang

J

,

Detterbeck

F

, et al.

European Society of Thoracic Surgeons Thymic Group Steering Committee. Outcome of primary neuroendocrine tumors of the thymus: a joint analysis of the International Thymic Malignancy Interest Group and the European Society of Thoracic Surgeons databases

.

J Thorac Cardiovasc Surg

.

2015

;

149

(

1

):

103

–

9.e2

.

8.

Lang

M

,

Hackert

T

,

Anamaterou

C

.

Long-term effect of everolimus in recurrent thymic neuroendocrine neoplasia

.

Clin Endocrinol

.

2021

;

95

(

5

):

744

–

51

.

9.

Crona

J

,

Björklund

P

,

Welin

S

,

Kozlovacki

G

,

Oberg

K

,

Granberg

D

.

Treatment, prognostic markers and survival in thymic neuroendocrine tumours. A study from a single tertiary referral centre

.

Lung Cancer

.

2013

;

79

(

3

):

289

–

93

.

10.

Gaur

P

,

Leary

C

,

Yao

JC

.

Thymic neuroendocrine tumors: a SEER database analysis of 160 patients

.

Ann Surg

.

2010

;

251

(

6

):

1117

–

21

.

11.

Ferolla

P

,

Falchetti

A

,

Filosso

P

,

Tomassetti

P

,

Tamburrano

G

,

Avenia

N

, et al.

Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series

.

J Clin Endocrinol Metab

.

2005

;

90

(

5

):

2603

–

9

.

12.

Soltysiak

J

,

Ostalska-Nowicka

D

,

Zaorska

K

,

Sterzyńska

K

,

Derwich

K

,

Zachwieja

J

.

Atypical thymic carcinoid manifesting with nephrotic-range proteinuria in a 7-year-old boy

.

Pediatr Nephrol

.

2017

;

32

(

8

):

1465

–

8

.

13.

Oberndorfer

S

.

Karzinoide Tumoren des Dünndarms

.

Frankf Z Pathol

.

1907

;

1

:

426

–

9

.

14.

Brierley

J

,

Gospodarowicz

MK

,

Wittekind

C

, editors.

Union for International cancer control. TNM classification of malignant tumours

. 8th ed.

Wiley-Blackwell

;

2017

. p.

1

–

241

.

15.

Koga

K

,

Matsuno

Y

,

Noguchi

M

,

Mukai

K

,

Asamura

H

,

Goya

T

, et al.

A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma

.

Pathol Int

.

1994

;

44

(

5

):

359

–

67

.

16.

Masaoka

A

,

Monden

Y

,

Nakahara

K

,

Tanioka

T

.

Follow-up study of thymomas with special reference to their clinical stages

.

Cancer

.

1981

;

48

(

11

):

2485

–

92

.

17.

WHO Classification of Tumours Editorial Board, Thoracic Tumours

.

WHO classification of tumours

. 5th ed.

Vol. 5

;

2021

.

18.

Petrini

I

,

Meltzer

PS

,

Kim

IK

,

Lucchi

M

,

Park

KS

,

Fontanini

G

, et al.

A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors

.

Nat Genet

.

2014

;

46

(

8

):

844

–

9

.

19.

Lang

M

,

Kazdal

D

,

Mohr

I

,

Anamaterou

C

.

Differences and similarities of GTF2I mutated thymomas in different Eurasian ethnic groups

.

Transl Lung Cancer Res

.

2023

;

12

(

9

):

1842

–

4

.

20.

Ye

L

,

Wang

W

,

Ospina

NS

,

Jiang

L

,

Christakis

I

,

Lu

J

, et al.

Clinical features and prognosis of thymic neuroendocrine tumours associated with multiple endocrine neoplasia type 1: a single-centre study, systematic review and meta-analysis

.

Clin Endocrinol

.

2017

;

87

(

6

):

706

–

16

.

21.

Pieterman

CRC

,

Valk

GD

.

Update on the clinical management of multiple endocrine neoplasia type 1

.

Clin Endocrinol

.

2022

;

97

(

4

):

409

–

23

.

22.

Manoharan

J

,

Albers

MB

,

Rinke

A

,

Adelmeyer

J

,

Görlach

J

,

Bartsch

DK

.

Multiple endocrine neoplasia type 1

.

Dtsch Arztebl Int

.

2024

;

121

(

16

):

527

–

33

.

23.

Pellegata

NS

,

Quintanilla-Martinez

L

,

Siggelkow

H

,

Samson

E

,

Bink

K

,

Höfler

H

, et al.

Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans

.

Proc Natl Acad Sci U S A

.

2006

;

103

(

42

):

15558

–

63

. Erratum in: Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):19213.

24.

Seabrook

A

,

Wijewardene

A

,

De Sousa

S

,

Wong

T

,

Sheriff

N

,

Gill

AJ

, et al.

MEN4, the MEN1 mimicker: a case series of three phenotypically heterogenous patients with unique CDKN1B mutations

.

J Clin Endocrinol Metab

.

2022

;

107

(

8

):

2339

–

49

.

25.

Fabbri

A

,

Cossa

M

,

Sonzogni

A

,

Bidoli

P

,

Canova

S

,

Cortinovis

D

, et al.

Thymus neuroendocrine tumors with CTNNB1 gene mutations, disarrayed ß-catenin expression, and dual intra-tumor Ki-67 labeling index compartmentalization challenge the concept of secondary high-grade neuroendocrine tumor: a paradigm shift

.

Virchows Arch

.

2017

;

471

(

1

):

31

–

47

.

26.

Seabrook

AJ

,

Harris

JE

,

Velosa

SB

,

Kim

E

,

McInerney-Leo

AM

,

Dwight

T

, et al.

Multiple endocrine tumors associated with germline MAX mutations: multiple endocrine neoplasia type 5

.

J Clin Endocrinol Metab

.

2021

;

106

(

4

):

1163

–

82

.

27.

Baudin

E

,

Caplin

M

,

Garcia-Carbonero

R

, et al.

On behalf of the ESMO Guidelines Committee. Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

.

Ann Oncol

.

2021

;

32

(

4

):

439

–

51

.

28.

Ekeblad

S

,

Sundin

A

,

Janson

ET

,

Welin

S

,

Granberg

D

,

Kindmark

H

, et al.

Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors

.

Clin Cancer Res

.

2007

;

13

(

10

):

2986

–

91

.

29.

Wang

X

,

Li

Y

,

Duan

J

,

Chen

Y

,

Yuan

B

,

Qi

Z

, et al.

Capecitabine and temozolomide as a promising therapy for advanced thymic atypical carcinoid

.

Oncologist

.

2019

;

24

(

6

):

798

–

802

.

30.

Muñoz Ruiz

AI

,

Calvo Elipe

A

,

Llorente Herrero

E

,

Guerrero Vega

E

,

Pato Alonso

S

,

Rodríguez Dorrego

R

, et al.

An ACTH- secreting carcinoid tumor of the thymus. A report of a new case

.

An Med Interna

.

1995

;

12

(

4

):

189

–

91

.

31.

Dham

A

,

Truskinovsky

AM

,

Dudek

AZ

.

Thymic carcinoid responds to neoadjuvant therapy with sunitinib and octreotide: a case report

.

J Thorac Oncol

.

2008

;

3

(

1

):

94

–

7

.

32.

Hamada

S

,

Masago

K

,

Mio

T

,

Hirota

S

,

Mishima

M

.

Good clinical response to imatinib mesylate in atypical thymic carcinoid with KIT overexpression

.

J Clin Oncol

.

2011

;

29

(

1

):

e9

–

10

.

33.

McEvoy

MP

,

Rich

BS

,

New

M

,

Tang

LH

,

La Quaglia

MP

.

Thymic carcinoid presenting with Cushing’s syndrome in a 17-year-old boy: a case report and review of the literature

.

J Clin Oncol

.

2011

;

29

(

25

):

e716

–

8

.

34.

Palmieri

GA

,

Buonerba

CA

,

Formisano

LA

.

Sunitinib in a MEN-1 patient with small cell neuroendocrine tumor of the thymus

.

Neuroendocrinology

.

2012

;

96

(

Suppl 1

):

524

.

35.

Komoda

S

,

Komoda

T

,

Knosalla

C

,

Pavel

ME

,

Morawietz

L

,

von Weikersthal

LF

, et al.

A giant neuroendocrine tumor of the thymus gland causing superior vena cava syndrome

.

Gen Thorac Cardiovasc Surg

.

2012

;

60

(

12

):

863

–

7

.

36.

Ose

N

,

Inoue

M

,

Morii

E

,

Shintani

Y

,

Sawabata

N

,

Okumura

M

.

Multimodality therapy for large cell neuroendocrine carcinoma of the thymus

.

Ann Thorac Surg

.

2013

;

96

(

4

):

e85

–

7

.

37.

Sugawara

K

,

Mizumoto

M

,

Numajiri

H

,

Ohno

T

,

Ohnishi

K

,

Ishikawa

H

, et al.

Proton beam therapy for a patient with a giant thymic carcinoid tumor and severe superior vena cava syndrome

.

Rare Tumors

.

2014

;

6

(

2

):

5177

.

38.

Tjalma

WA

.

Successful pregnancies after the treatment of a thymic carcinoid

.

Case Rep Obstet Gynecol

.

2015

;

2015

:

802713

.

39.

Oda

N

,

Miyahara

N

,

Tabata

M

,

Minami

D

,

Ninomiya

K

,

Kanehiro

A

, et al.

Pneumocystis pneumonia concomitant with ectopic ACTH syndrome caused by a large cell neuroendocrine carcinoma of the thymus

.

Intern Med

.

2017

;

56

(

5

):

551

–

5

.

40.

Cahajlová

R

,

Černá

M

,

Kiňová

S

.

Multimodálna liečba tymického karcinoidu: kazuistika [Multimodal treatment of thymic carcinoid: a case report]

.

Vnitr Lek

.

2019 Spring

;

65

(

5

):

363

–

8

.

41.

Baranowska-Jurkun

A

,

Szychlińska

M

,

Matuszewski

W

,

Modzelewski

R

,

Bandurska-Stankiewicz

E

.

ACTH-dependent hypercortisolemia in a patient with a pituitary microadenoma and an atypical carcinoid tumour of the thymus

.

Medicina

.

2019

;

55

(

12

):

759

.

42.

Sakane

T

,

Nakano

T

,

Hagui

E

,

Haneda

H

,

Okuda

K

.

Everolimus in combination with octreotide LAR in thymic atypical carcinoid

.

Thorac Cancer

.

2023

;

14

(

15

):

1404

–

7

.

43.

Rumbinaitė

E

,

Dirsienė

R

,

Vaitiekus

D

,

Poškienė

L

,

Žūkaitė

G

,

Stankevičienė

Š

, et al.

Is this dyspnea because of coronary artery disease? A rare case report of primary neuroendocrine tumor in anterior mediastinum

.

Perfusion

.

2024

;

39

(

4

):

854

–

8

.

44.

Dosios

T

,

Nikou

G

,

Toubanakis

C

,

Filippides

T

,

Papachristou

D

.

Multimodality treatment of neuroendocrine tumors of the thymus

.

Thorac Cardiovasc Surg

.

2005

;

53

(

5

):

305

–

9

.

45.

Van Essen

M

,

Krenning

EP

,

Bakker

WH

,

de Herder

WW

,

van Aken

MO

,

Kwekkeboom

DJ

.

Peptide receptor radionuclide therapy with 177Lu-octreotate in patients with foregut carcinoid tumours of bronchial, gastric and thymic origin

.

Eur J Nucl Med Mol Imaging

.

2007

;

34

(

8

):

1219

–

27

.

46.

Saranga-Perry

V

,

Morse

B

,

Centeno

B

,

Kvols

L

,

Strosberg

J

.

Treatment of metastatic neuroendocrine tumors of the thymus with capecitabine and temozolomide: a case series

.

Neuroendocrinology

.

2013

;

97

(

4

):

318

–

21

.

47.

Yliaska

I

,

Tokola

H

,

Ebeling

T

,

Kuismin

O

,

Ukkola

O

,

Koivikko

ML

, et al.

Thymic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1

.

Endocrine

.

2022

;

77

(

3

):

527

–

37

.

48.

Lang

M

,

Anamaterou

C

.

Thymic neuroendocrine neoplasia: therapy with everolimus

.

Neuroendocrinology

.

2016

;

103

(

s1

):

105

. Abstracts of the 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease. March 9-11, 2016, Barcelona, Spain.

49.

Tiffet

O

,

Nicholson

AG

,

Ladas

G

,

Sheppard

MN

,

Goldstraw

P

.

A clinicopathologic study of 12 neuroendocrine tumors arising in the thymus

.

Chest

.

2003

;

124

(

1

):

141

–

6

.

50.

Cardillo

G

,

Rea

F

,

Lucchi

M

,

Paul

MA

,

Margaritora

S

,

Carleo

F

, et al.

Primary neuroendocrine tumors of the thymus: a multicenter experience of 35 patients

.

Ann Thorac Surg

.

2012

;

94

(

1

):

241

–

6

.

51.

Lang

M

,

Pausch

TM

,

Anamaterou

C

.

Thymic neuroendocrine neoplasms: what we know, what we don’t know, and what to do about it

.

Transl Cancer Res

.

2023

;

12

(

1

):

1

–

3

.

52.

Lang

M

,

Pausch

T

,

Anamaterou

C

.

Characterizing thymic tumors-how to track down rare diseases

.

J Thorac Dis

.

2022

;

14

(

12

):

4571

–

3

.

53.

Ferolla

P

,

Brizzi

MP

,

Meyer

T

,

Mansoor

W

,

Mazieres

J

,

Do Cao

C

, et al.

Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomised, phase 2 trial

.

Lancet Oncol

.

2017

;

18

(

12

):

1652

–

64

.

54.

Maasberg

S

,

Pape

UF

,

Fottner

C

,

Goretzki

PE

,

Anlauf

M

,

Hörsch

D

, et al.

Neuroendocrine neoplasia within the German NET registry

.

Z Gastroenterol

.

2018

;

56

(

10

):

1237

–

46

.

55.

Chan

JA

,

Geyer

S

,

Zemla

T

,

Knopp

MV

,

Behr

S

,

Pulsipher

S

, et al.

Phase 3 trial of cabozantinib to treat advanced neuroendocrine tumors

.

N Engl J Med

.

2025

;

392

(

7

):

653

–

65

.

56.

Sullivan

JL

,

Weksler

B

.

Neuroendocrine tumors of the thymus: analysis of factors affecting survival in 254 patients

.

Ann Thorac Surg

.

2017

;

103

(

3

):

935

–

9

.

57.

Taskin

OC

,

Clarke

CN

,

Erkan

M

,

Tsai

S

,

Evans

DB

,

Adsay

V

.

Pancreatic neuroendocrine neoplasms: current state and ongoing controversies on terminology, classification and prognostication

.

J Gastrointest Oncol

.

2020

;

11

(

3

):

548

–

58

.

58.

Engelbreth-Holm

J

.

Benign bronchial adenomas

.

Acta Chirurgica Scandinavica

.

1944

;

90

:

383

.

59.

Gibril

F

,

Chen

YJ

,

Schrump

DS

,

Vortmeyer

A

,

Zhuang

Z

,

Lubensky

IA

, et al.

Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1

.

J Clin Endocrinol Metab

.

2003

;

88

(

3

):

1066

–

81

.

60.

Teh

BT

,

McArdle

J

,

Chan

SP

,

Menon

J

,

Hartley

L

,

Pullan

P

, et al.

Clinicopathologic studies of thymic carcinoids in multiple endocrine neoplasia type 1

.

Medicine

.

1997

;

76

(

1

):

21

–

9

.

61.

Li

HR

,

Gao

J

,

Jin

C

,

Jiang

JH

,

Ding

JY

.

Comparison between CT and MRI in the diagnostic accuracy of thymic masses

.

J Cancer

.

2019

;

10

(

14

):

3208

–

13

.

62.

Rampp

RD

,

Mancilla

EE

,

Adzick

NS

,

Levine

MA

,

Kelz

RR

,

Fraker

DL

, et al.

Single gland, ectopic location: adenomas are common causes of primary hyperparathyroidism in children and adolescents

.

World J Surg

.

2020

;

44

(

5

):

1518

–

25

.